Fibrovascular Pigment Epithelial Detachment

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2018-07-16
Clinical Trial Update: Open Label to Study to Evaluate Effect of Alfilbercept on Patients With (FVPED) Fibrovascular Pigment Epithelial Detachment [Phase 4]
Phase 4 open-label trial evaluating alfilbercept for fibrovascular pigment epithelial detachment has been withdrawn.